<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33803356</PMID><DateCompleted><Year>2021</Year><Month>08</Month><Day>12</Day></DateCompleted><DateRevised><Year>2021</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><Issue>3</Issue><PubDate><Year>2021</Year><Month>Mar</Month><Day>09</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Safety and Immunogenicity of a Stable, Cold-Adapted, Temperature-Sensitive/Conditional Lethal Enterovirus A71 in Monkey Study.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">438</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v13030438</ELocationID><Abstract><AbstractText>Enterovirus A71 (EV-A71) and coxsackievirus A16 (CA16) are major etiological agents of hand foot and mouth disease (HFMD) in children, which may result in fatal neurological complications. The development of safe, cost effective vaccines against HFMD, especially for use in developing countries, is still a top public health priority. We have successfully generated a stable, cold-adapted, temperature sensitive/conditional lethal EV-A71 through adaptive culturing in Vero cells at incrementally lower cultivation temperatures. An additional 40 passages at an incubation temperature of 28 &#xb0;C, and a temperature reversion study at an incubation temperature of 37 &#xb0;C and 39.5 &#xb0;C, reveals the virus's phenotypic and genetic stability at the predefined culture conditions. Six unique mutations (two in noncoding regions and four in nonstructural protein-coding genes) in combination may have contributed to its stable phenotype and inability to fully revert to its original wild phenotype. The safety and immunogenicity of this stable, cold-adapted, temperature sensitive/conditional lethal EV-A71 was performed in six monkeys. None of the inoculated monkeys developed any obvious clinical illness except one which developed a transient spike of fever. No gross postmortem lesion or abnormal histological finding was noted for all monkeys at autopsy. No virus was reisolated although EV-A71 specific RNA was detected in serum samples collected on both day 4 and day 8 postinoculation. Only EV-A71 RNA and viral antigen were detected in the spleen homogenate and peripheral blood mononuclear cells, respectively, collected on day 4. The two remaining monkeys developed good humoral immune response on day 14 and day 30 post-inoculation.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chua</LastName><ForeName>Kaw Bing</ForeName><Initials>KB</Initials><AffiliationInfo><Affiliation>Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, Singapore 117604, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ng</LastName><ForeName>Qimei</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0002-4475-4424</Identifier><AffiliationInfo><Affiliation>Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, Singapore 117604, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meng</LastName><ForeName>Tao</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, Singapore 117604, Singapore.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jia</LastName><ForeName>Qiang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Temasek Life Sciences Laboratory, 1 Research Link, National University of Singapore, Singapore 117604, Singapore.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>03</Month><Day>09</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000956">Antigens, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012367">RNA, Viral</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014613">Vaccines, Attenuated</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="Y">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000956" MajorTopicYN="N">Antigens, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008252" MajorTopicYN="N">Macaca fascicularis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012367" MajorTopicYN="N">RNA, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014613" MajorTopicYN="N">Vaccines, Attenuated</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">attenuation</Keyword><Keyword MajorTopicYN="N">candidate vaccine</Keyword><Keyword MajorTopicYN="N">coxsackievirus A16</Keyword><Keyword MajorTopicYN="N">enterovirus A71</Keyword><Keyword MajorTopicYN="N">temperature sensitive and conditional lethal</Keyword></KeywordList><CoiStatement>All authors declare there are no conflict of interest with their work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>2</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>3</Month><Day>5</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>4</Month><Day>3</Day><Hour>1</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>4</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>8</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>3</Month><Day>9</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33803356</ArticleId><ArticleId IdType="pmc">PMC8001754</ArticleId><ArticleId IdType="doi">10.3390/v13030438</ArticleId><ArticleId IdType="pii">v13030438</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Alexander J.P., Baden L., Pallansch M.A., Anderson L.J. Enterovirus 71 Infections and Neurologic Disease&#x2014;United States, 1977&#x2013;1991. J. Infect. Dis. 1994;169:905&#x2013;908. doi: 10.1093/infdis/169.4.905.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/169.4.905</ArticleId><ArticleId IdType="pubmed">8133108</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnick J.L. Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses, and Newer Enteroviruses. In: Fields B.N., Knipe D.M., Howley P.M., editors. Fields Virology. 3rd ed. Lippincott-Raven; Philadelphia, PA, USA: 1996. pp. 655&#x2013;712.</Citation></Reference><Reference><Citation>Blomberg J., Lycke E., Ahlfors K., Johnsson T., Wolontis S., Von Zeipel G. New enterovirus type associated with epidemic of aseptic meningitis and/or hand, foot, and mouth disease. Lancet. 1974;304:112. doi: 10.1016/S0140-6736(74)91684-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(74)91684-5</ArticleId><ArticleId IdType="pubmed">4136956</ArticleId></ArticleIdList></Reference><Reference><Citation>Bible J.M., Iturriza-Gomara M., Megson B., Brown D., Pantelidis P., Earl P., Bendig J., Tong C.Y.W. Molecular epidemiology of human entrovirus 71 in the United Kingdom from 1998 to 2006. J. Clin. Microbiol. 2008;46:3192&#x2013;3200. doi: 10.1128/JCM.00628-08.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.00628-08</ArticleId><ArticleId IdType="pmc">PMC2566106</ArticleId><ArticleId IdType="pubmed">18650362</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B.A., Oberste M.S., Alexander J.P., Jr., Kennett M.L., Pallansch M.A. Molecular epidemiology and evolution of enterovirus 71 strains isolated from 1970 to 1998. J. Virol. 1999;73:9969&#x2013;9975. doi: 10.1128/JVI.73.12.9969-9975.1999.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.73.12.9969-9975.1999</ArticleId><ArticleId IdType="pmc">PMC113047</ArticleId><ArticleId IdType="pubmed">10559310</ArticleId></ArticleIdList></Reference><Reference><Citation>Bessaud M., Razafindratsimandresy R., Nougair&#xe8;de A., Joffret M.-L., Deshpande J.M., Dubot-P&#xe9;r&#xe8;s A., H&#xe9;raud J.-M., De Lamballerie X., Delpeyroux F., Bailly J.-L. Molecular Comparison and Evolutionary Analyses of VP1 Nucleotide Sequences of New African Human Enterovirus 71 Isolates Reveal a Wide Genetic Diversity. PLoS ONE. 2014;9:e90624. doi: 10.1371/journal.pone.0090624.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0090624</ArticleId><ArticleId IdType="pmc">PMC3944068</ArticleId><ArticleId IdType="pubmed">24598878</ArticleId></ArticleIdList></Reference><Reference><Citation>Saxena V.K., Sane S., Nadkarni S.S., Sharma D.K., Deshpande J.M. Genetic diversity of enterovirus A71, India. Emerg. Infect. Dis. 2015;21:123&#x2013;126. doi: 10.3201/eid2101.140743.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2101.140743</ArticleId><ArticleId IdType="pmc">PMC4285237</ArticleId><ArticleId IdType="pubmed">25531549</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov M., Voroshilova M., Shindarov L., Lavrova I., Gracheva L., Koroleva G., Vasilenko S., Brodvarova I., Nikolova M., Gyurova S., et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch. Virol. 1979;60:329&#x2013;340. doi: 10.1007/BF01317504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01317504</ArticleId><ArticleId IdType="pubmed">228639</ArticleId></ArticleIdList></Reference><Reference><Citation>Shindarov L.M., Chumakov M.P., Voroshilova M.K., Bojinov S., Vasilenko S.M., Iordanov I., Kirov I.D., Kamenov E., Leshchinskaya E.V., Mitov G., et al. Epidemiological, clinical, and pathomorphological characteristics of epidemic poliomyelitis-like disease caused by enterovirus 71. J. Hyg. Epidemiol. Microbiol. Immunol. 1979;23:284&#x2013;295.</Citation><ArticleIdList><ArticleId IdType="pubmed">231067</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy G., Tak&#xe1;tsy S., Kuk&#xe1;n E., Mih&#xe1;ly I., D&#xf6;m&#xf6;k I. Virological diagnosis of enterovirus type 71 infections: Experiences gained during an epidemic of acute CNS diseases in Hungary in 1978. Arch. Virol. 1982;71:217&#x2013;227. doi: 10.1007/BF01314873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01314873</ArticleId><ArticleId IdType="pubmed">6285858</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennett M.L., Birch C.J., Lewis F.A., Yung A.P., Locarnini S.A., Gust I.D. Enterovirus type 71 infection in Melbourne. Bull. EHO. 1974;51:609&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2366271</ArticleId><ArticleId IdType="pubmed">4377551</ArticleId></ArticleIdList></Reference><Reference><Citation>Deibel R., Gross L.L., Collins D.N. Isolation of a New Enterovirus. Exp. Biol. Med. 1975;148:203&#x2013;207. doi: 10.3181/00379727-148-38506.</Citation><ArticleIdList><ArticleId IdType="doi">10.3181/00379727-148-38506</ArticleId><ArticleId IdType="pubmed">165523</ArticleId></ArticleIdList></Reference><Reference><Citation>Chonmaitree T., Menegus M.A., Schervish-Swierkosz E.M., Schwalenstocker E. Enterovirus 71 infection: A Report of an outbreak with two cases of paralysis and a review of the literature. Pediatrics. 1981;67:489&#x2013;493.</Citation><ArticleIdList><ArticleId IdType="pubmed">7254970</ArticleId></ArticleIdList></Reference><Reference><Citation>Samuda G.M., Chang W.K., Yeung C.Y., Tang P.S. Monoplegia caused by enterovirus 71: An outbreak in Hong Kong. Pediatr. Infect. Dis. 1987;6:206&#x2013;208. doi: 10.1097/00006454-198702000-00013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-198702000-00013</ArticleId><ArticleId IdType="pubmed">3562141</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert G.L., Dickson K.E., Waters M.-J., Kennett M.L., Land S.A., Sneddon M. Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr. Infect. Dis. J. 1988;7:484&#x2013;487. doi: 10.1097/00006454-198807000-00007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-198807000-00007</ArticleId><ArticleId IdType="pubmed">2841639</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayward J.C., Gillespie S.M., Kaplan K.M., Packer R., Pallansch M., Plotkin S., Schonberger L.B. Outbreak of poliomyelitis-like paralysis associated with enterovirus 71. Pediatr. Infect. Dis. J. 1989;8:611&#x2013;615. doi: 10.1097/00006454-198909000-00009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00006454-198909000-00009</ArticleId><ArticleId IdType="pubmed">2797956</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiwara A., Tagaya I., Yoneyama T. Epidemic of Hand, Foot and Mouth Disease Associated with Enterovirus 71 Infection. Intervirology. 1978;9:60&#x2013;63. doi: 10.1159/000148922.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000148922</ArticleId><ArticleId IdType="pubmed">202573</ArticleId></ArticleIdList></Reference><Reference><Citation>Tagaya I., Takayama R., Hagiwara A. A large scale epidemic of hand, foot, mouth disease associated with enterovirus 71 infection in Japan in 1978. Jpn. J. Med. Sci. Biol. 1981;34:191&#x2013;196. doi: 10.7883/yoken1952.34.191.</Citation><ArticleIdList><ArticleId IdType="doi">10.7883/yoken1952.34.191</ArticleId><ArticleId IdType="pubmed">6273621</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishimaru Y., Nakano S., Yamaoka K., Takami S. Outbreaks of hand, foot, mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch. Dis. Child. 1980;55:583&#x2013;588. doi: 10.1136/adc.55.8.583.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/adc.55.8.583</ArticleId><ArticleId IdType="pmc">PMC1627055</ArticleId><ArticleId IdType="pubmed">6254449</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum L.C.S., Lam S.K., Wong K.T., Chua K.B., Goh A.Y.T. Neurologic pulmonary oedema and enterovirus 71 encephalomyelitis. Lancet. 1998;352:1391. doi: 10.1016/S0140-6736(05)60789-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(05)60789-1</ArticleId><ArticleId IdType="pubmed">9802304</ArticleId></ArticleIdList></Reference><Reference><Citation>Lum L.C.S., Wong K.T., Lam S.K., Chua K.B., Goh A.Y.T., Lim W.L., Ong B.B., Paul G., AbuBakar S., Lambert M. Fatal Enterovirus 71 encephalitis. J. Pediatr. 1998;133:795&#x2013;798. doi: 10.1016/S0022-3476(98)70155-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0022-3476(98)70155-6</ArticleId><ArticleId IdType="pubmed">9842048</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin T.-Y., Chang L.-Y., Huang Y.-C. Fulminant neurogenic pulmonary oedema with hand, foot, and mouth disease. Lancet. 1998;352:367&#x2013;368. doi: 10.1016/S0140-6736(98)24031-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(98)24031-1</ArticleId><ArticleId IdType="pubmed">9717926</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J.J., Wang J.R., Liu C.C., Yang H.B., Su I.J. An outbreak of enterovirus 71 infection in Taiwan 1998: A comprehensive pathological, virological, and molecular study on a case of fulminant encephalitis. J. Clin. Virol. 2000;17:13&#x2013;22. doi: 10.1016/S1386-6532(00)00067-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(00)00067-6</ArticleId><ArticleId IdType="pubmed">10814934</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C.C., Tseng H.W., Wang S.M., Wang J.R., Su I.J. An outbreak of enteovirus 71 infection in Taiwan, 1998: Epidemiologic and clinical manifestations. J. Clin. Virol. 2000;17:23&#x2013;30. doi: 10.1016/S1386-6532(00)00068-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(00)00068-8</ArticleId><ArticleId IdType="pubmed">10814935</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J.R., Tsai H.P., Chen P.F., Lai Y.J., Yan J.J., Kiang D., Lin K.H., Liu C.C., Su I.J. An outbreak of enteovirus 71 infection in Taiwan, 1998. II. Laboratory diagnosis and genetic analysis. J. Clin. Virol. 2000;17:91&#x2013;99. doi: 10.1016/S1386-6532(00)00079-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1386-6532(00)00079-2</ArticleId><ArticleId IdType="pubmed">10942089</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinese Center for Disease Control and Prevention. Office of the World Health Organization in China . Report on the Hand, Foot and Mouth Disease Outbreak in Fuyang City, Anhui Province and the Prevention and Control in China. World Health Organization; Beijing, China: 2008.</Citation></Reference><Reference><Citation>Yang F., Zhng T., Hu Y., Wang X., Du J., Li YSun S., Sun X., Li Z., Jin Q. Survey of enterovirus infections from hand, foot and mouth disease outbreak in China, 2009. Virol. J. 2011;8:508. doi: 10.1186/1743-422X-8-508.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-508</ArticleId><ArticleId IdType="pmc">PMC3227625</ArticleId><ArticleId IdType="pubmed">22054534</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M., El Khatib N.F., Tu S., Ren P., Xu S., Zhu Q., Mo X., Pu D., Wang X., Altmeyer R. Seroepidemiology of Enterovirus 71 infection prior to the 2011 season in children in Shanghai. J. Clin. Virol. 2012;53:285&#x2013;289. doi: 10.1016/j.jcv.2011.12.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.12.025</ArticleId><ArticleId IdType="pubmed">22265829</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu C.-N., Lin Y.-C., Fann C., Liao N.-S., Shih S.-R., Ho M.-S. Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus. Vaccine. 2001;20:895&#x2013;904. doi: 10.1016/S0264-410X(01)00385-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0264-410X(01)00385-1</ArticleId><ArticleId IdType="pubmed">11738755</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu C.-H., Chu C., He C.-C., Lin T.-Y. Protection of neonatal mice from lethal enterovirus 71 infection by maternal immunization with attenuated Salmonella enterica serovar Typhimurium expressing VP1 of enterovirus 71. Microbes Infect. 2006;8:1671&#x2013;1678. doi: 10.1016/j.micinf.2006.01.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2006.01.021</ArticleId><ArticleId IdType="pubmed">16815726</ArticleId></ArticleIdList></Reference><Reference><Citation>Tung W.S., Abu Bakar S., Sekawi Z., Rosli R. DNA vaccine constructs against enterovirus 71 elicit immune response in mice. Genet. Vaccines Ther. 2007;5:6. doi: 10.1186/1479-0556-5-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1479-0556-5-6</ArticleId><ArticleId IdType="pmc">PMC3225814</ArticleId><ArticleId IdType="pubmed">17445254</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung Y.-C., Ho M.-S., Wu J.-C., Chen W.-J., Huang J.-H., Chou S.-T., Hu Y.-C. Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge. Vaccine. 2008;26:1855&#x2013;1862. doi: 10.1016/j.vaccine.2008.01.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2008.01.058</ArticleId><ArticleId IdType="pubmed">18329759</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H.-L., Huang J.-Y., Chu T.-W., Tsai T.-C., Hung C.-M., Lin C.-C., Liu F.-C., Wang L.-C., Chen Y.-J., Lin M.-F., et al. Expression of VP1 protein in the milk of transgenic mice: A potential oral vaccine protects against enterovirus 71 infection. Vaccine. 2008;26:2882&#x2013;2889. doi: 10.1016/j.vaccine.2008.03.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2008.03.041</ArticleId><ArticleId IdType="pubmed">18450335</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong K.C., Devi S., Cardosa M.J., Wong K.T. Formaldehyde-Inactivated Whole-Virus Vaccine Protects a Murine Model of Enterovirus 71 Encephalomyelitis against Disease. J. Virol. 2010;84:661&#x2013;665. doi: 10.1128/JVI.00999-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00999-09</ArticleId><ArticleId IdType="pmc">PMC2798416</ArticleId><ArticleId IdType="pubmed">19864378</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.-W., Lee Y.-P., Wang Y.-F., Yu C.-K. Formaldehyde-inactivated human enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine. Vaccine. 2011;29:2772&#x2013;2776. doi: 10.1016/j.vaccine.2011.01.094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2011.01.094</ArticleId><ArticleId IdType="pubmed">21315698</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee M.-S., Chang L.-Y. Development of enterovirus 71 vaccines. Expert Rev. Vaccines. 2010;9:149&#x2013;156. doi: 10.1586/erv.09.152.</Citation><ArticleIdList><ArticleId IdType="doi">10.1586/erv.09.152</ArticleId><ArticleId IdType="pubmed">20109026</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang D., Lu J., Lu J. Enterovirus 71 vaccine: Close but still far. Int. J. Infect. Dis. 2010;14:e739&#x2013;e743. doi: 10.1016/j.ijid.2009.12.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2009.12.002</ArticleId><ArticleId IdType="pmc">PMC7110504</ArticleId><ArticleId IdType="pubmed">20400350</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabin A.B. Oral Poliovirus Vaccine: History of Its Development and Use and Current Challenge to Eliminate Poliomyelitis from the World. J. Infect. Dis. 1985;151:420&#x2013;436. doi: 10.1093/infdis/151.3.420.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/151.3.420</ArticleId><ArticleId IdType="pubmed">2982959</ArticleId></ArticleIdList></Reference><Reference><Citation>Sutter R.W., Kew O.M., Cochi S.L., Aylward R.B. Poliovirus vaccine-live. In: Plotkin S.A., Orenstein W.A., Offit P.A., editors. Vaccines. 6th ed. Elsevier Saunders; Philadelphia, PA, USA: 2012. pp. 598&#x2013;645. Section 2. Chapter 28.</Citation></Reference><Reference><Citation>Chua K.B., Chua B.H., Lee C.S.M., Chem Y.K., Ismail N., Kiyu A., Kumarasamy V. Genetic diversity of enterovirus 71 isolated from cases of hand, foot and mouth disease in the 1997, 2000 and 2005 outbreaks, Peninsular Malaysia. Malays. J. Pathol. 2007;29:69&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">19108398</ArticleId></ArticleIdList></Reference><Reference><Citation>Dougherty R.M. Animal virus titration technique. In: Harris R.J.C., editor. Techniques in Experimental Virology. Academic Press; London, UK: New York, NY, USA: 1964. pp. 169&#x2013;224. Chapter 6.</Citation></Reference><Reference><Citation>Reed L.J., Muench H. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 1938;27:493&#x2013;497.</Citation></Reference><Reference><Citation>Tan E.L., Chow V.T.K., Kumarasinghe G., Lin R.T.P., Mackay I.M., Sloots T.P., Poh C.L. Specific detection of enterovirus 71 directly from clinical specimens using real-time RT-PCR hybridization probe assay. Mol. Cell. Probes. 2006;20:135&#x2013;140. doi: 10.1016/j.mcp.2005.11.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcp.2005.11.003</ArticleId><ArticleId IdType="pubmed">16460910</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z., Yu M., Zhang H., Wang H.-Y., Wang L.-F. Improved rapid amplification of cDNA ends (RACE) for mapping both the 5&#x2032; and 3&#x2032; terminal sequences of paramyxovirus genomes. J. Virol. Methods. 2005;130:154&#x2013;156. doi: 10.1016/j.jviromet.2005.06.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2005.06.022</ArticleId><ArticleId IdType="pubmed">16076500</ArticleId></ArticleIdList></Reference><Reference><Citation>Rice P., Longden I., Bleasby A. EMBOSS: The European Molecular Biology Open Software Suite. Trends Genet. 2000;16:276&#x2013;277. doi: 10.1016/S0168-9525(00)02024-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-9525(00)02024-2</ArticleId><ArticleId IdType="pubmed">10827456</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall T. BioEdit: A user-friendly biological sequence alignment editor and analysis programme for Windows 95/98/NT. Nucleic Acids Symp. Res. 1997;41:95&#x2013;98.</Citation></Reference><Reference><Citation>Zhou Y., Li J.-X., Jin P.-F., Wang Y.-X., Zhu F.-C. Enterovirus 71: A whole virion inactivated enterovirus 71 vaccine. Expert Rev. Vaccines. 2016;15:803&#x2013;813. doi: 10.1080/14760584.2016.1191357.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14760584.2016.1191357</ArticleId><ArticleId IdType="pubmed">27206811</ArticleId></ArticleIdList></Reference><Reference><Citation>McGoldrick A., Macadam A.J., Dunn G., Rowe A., Burlison J., Minor P.D., Meredith J., Evans D.J., Almond J.W. Role of mutations G-480 and C-6203 in the attenuation phenotype of Sabin type 1 poliovirus. J. Virol. 1995;69:7601&#x2013;7605. doi: 10.1128/JVI.69.12.7601-7605.1995.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.69.12.7601-7605.1995</ArticleId><ArticleId IdType="pmc">PMC189699</ArticleId><ArticleId IdType="pubmed">7494267</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M., Ami Y., Wakita T., Shimizu H. Cooperative Effect of the Attenuation Deterrminants Derived from Poliovirus 1 Strain Is Essential for Attenuation of Enterovirus 71 in the NOD/SCID Mouse Infection Model. J. Virol. 2008;82:1787&#x2013;1795. doi: 10.1128/JVI.01798-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01798-07</ArticleId><ArticleId IdType="pmc">PMC2258712</ArticleId><ArticleId IdType="pubmed">18057246</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagiwara A., Yoneyama T., Hashimoto I. Isolation of a Temperature-sensitive Strain of Enterovirus 71 with Reduced Neurovirulence for Monkeys. J. Gen. Virol. 1983;64:499&#x2013;502. doi: 10.1099/0022-1317-64-2-499.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/0022-1317-64-2-499</ArticleId><ArticleId IdType="pubmed">6300298</ArticleId></ArticleIdList></Reference><Reference><Citation>Hashimoto I., Hagiwara A. Comparative studies on the neurovirulence of temperature-sensitive and temperature-resistant viruses of enterovirus 71 in monkeys. Acta Neuropathol. 1983;60:266&#x2013;270. doi: 10.1007/BF00691875.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF00691875</ArticleId><ArticleId IdType="pubmed">6310928</ArticleId></ArticleIdList></Reference><Reference><Citation>Arit C.M., Shimizu H., Nagata N., Ami Y., Suzaki Y., Sata T., Iwasaki T., Miyamura T. Temperature-sensitive mutants of enterovirus 71 show attenuation in cynomolgus monkeys. J. Gen. Virol. 2005;86:1391&#x2013;1401. doi: 10.1099/vir.0.80784-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.80784-0</ArticleId><ArticleId IdType="pubmed">15831951</ArticleId></ArticleIdList></Reference><Reference><Citation>Christopher U.T. Hellen and Eckard Wimmer. Enterovirus Genetics. In: Rotbart H.H., editor. Human Enterovirus Infections. ASM Press; Washington, DC, USA: 2005. pp. 25&#x2013;72. Chapter 2.</Citation></Reference><Reference><Citation>Johnsonand K.L., Sarnow P. Viral RNA Synthesis. In: Rotbart H.H., editor. Human Enterovirus Infections. ASM Press; Washington, DC, USA: 2005. pp. 95&#x2013;112. Chapter 4.</Citation></Reference><Reference><Citation>Sanders B.P., de Los Rios Oakes I., van Hoek V., Bockstal V., Kamphuis T., Uil T.G., Song Y., Cooper G., Crawt L.E., Mart&#xed;n J., et al. Cold-adapted viral attenuation (CAVA): Highly temperature sensitive polioviruses as novel vaccine strains for a next generation inactivated poliovirus vaccine. PLoS Pathog. 2016 doi: 10.1371/journal.ppat.1005483.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005483</ArticleId><ArticleId IdType="pmc">PMC4816566</ArticleId><ArticleId IdType="pubmed">27032093</ArticleId></ArticleIdList></Reference><Reference><Citation>Hallerand A.A., Semler B.L. Translation and Host Cell Shutoff. In: Rotbart H.H., editor. Human Enterovirus Infections. ASM Press; Washington, DC, USA: 2005. pp. 113&#x2013;133. Chapter 5.</Citation></Reference><Reference><Citation>Domingo E., Sheldon J., Perales C. Viral Quasispecies Evolution. Microbiol. Mol. Biol. Rev. 2012;76:159&#x2013;216. doi: 10.1128/MMBR.05023-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.05023-11</ArticleId><ArticleId IdType="pmc">PMC3372249</ArticleId><ArticleId IdType="pubmed">22688811</ArticleId></ArticleIdList></Reference><Reference><Citation>Lauring A.S., Andino R. Quasispecies Theory and the Behavior of RNA Viruses. PLoS Pathog. 2010;6:e1001005. doi: 10.1371/journal.ppat.1001005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1001005</ArticleId><ArticleId IdType="pmc">PMC2908548</ArticleId><ArticleId IdType="pubmed">20661479</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>